Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period

Perinatal brain injury is a major cause of morbidity and long-standing disability in newborns. Hypothermia is the only therapy approved to attenuate brain injury in the newborn. However, this treatment is unfortunately only partially neuroprotective and can only be used to treat hypoxic-ischemic enc...

Full description

Bibliographic Details
Main Authors: Clémence Disdier, Xiaodi Chen, Jeong-Eun Kim, Steven W. Threlkeld, Barbara S. Stonestreet
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Brain Sciences
Subjects:
Online Access:http://www.mdpi.com/2076-3425/8/6/101
_version_ 1819120359927971840
author Clémence Disdier
Xiaodi Chen
Jeong-Eun Kim
Steven W. Threlkeld
Barbara S. Stonestreet
author_facet Clémence Disdier
Xiaodi Chen
Jeong-Eun Kim
Steven W. Threlkeld
Barbara S. Stonestreet
author_sort Clémence Disdier
collection DOAJ
description Perinatal brain injury is a major cause of morbidity and long-standing disability in newborns. Hypothermia is the only therapy approved to attenuate brain injury in the newborn. However, this treatment is unfortunately only partially neuroprotective and can only be used to treat hypoxic-ischemic encephalopathy in full term infants. Therefore, there is an urgent need for adjunctive therapeutic strategies. Post-ischemic neuro-inflammation is a crucial contributor to the evolution of brain injury in neonates and constitutes a promising therapeutic target. Recently, we demonstrated encouraging neuroprotective capacities of anti-cytokine monoclonal antibodies (mAbs) in an ischemic-reperfusion (I/R) model of brain injury in the ovine fetus. The purpose of this review is to summarize the current knowledge regarding the inflammatory response in the perinatal sheep brain after I/R injury and to review our recent findings regarding the beneficial effects of treatment with anti-cytokine mAbs.
first_indexed 2024-12-22T06:19:25Z
format Article
id doaj.art-246aa4d8ad784fb8995656c9b152cab0
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-12-22T06:19:25Z
publishDate 2018-06-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-246aa4d8ad784fb8995656c9b152cab02022-12-21T18:36:00ZengMDPI AGBrain Sciences2076-34252018-06-018610110.3390/brainsci8060101brainsci8060101Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal PeriodClémence Disdier0Xiaodi Chen1Jeong-Eun Kim2Steven W. Threlkeld3Barbara S. Stonestreet4Department of Pediatrics, Women & Infants Hospital of Rhode Island, The Alpert Medical School of Brown University, Providence, RI 02905, USADepartment of Pediatrics, Women & Infants Hospital of Rhode Island, The Alpert Medical School of Brown University, Providence, RI 02905, USADepartment of Pediatrics, Women & Infants Hospital of Rhode Island, The Alpert Medical School of Brown University, Providence, RI 02905, USADepartment of Neuroscience, Regis College, Weston, MA 02493, USADepartment of Pediatrics, Women & Infants Hospital of Rhode Island, The Alpert Medical School of Brown University, Providence, RI 02905, USAPerinatal brain injury is a major cause of morbidity and long-standing disability in newborns. Hypothermia is the only therapy approved to attenuate brain injury in the newborn. However, this treatment is unfortunately only partially neuroprotective and can only be used to treat hypoxic-ischemic encephalopathy in full term infants. Therefore, there is an urgent need for adjunctive therapeutic strategies. Post-ischemic neuro-inflammation is a crucial contributor to the evolution of brain injury in neonates and constitutes a promising therapeutic target. Recently, we demonstrated encouraging neuroprotective capacities of anti-cytokine monoclonal antibodies (mAbs) in an ischemic-reperfusion (I/R) model of brain injury in the ovine fetus. The purpose of this review is to summarize the current knowledge regarding the inflammatory response in the perinatal sheep brain after I/R injury and to review our recent findings regarding the beneficial effects of treatment with anti-cytokine mAbs.http://www.mdpi.com/2076-3425/8/6/101braincytokinesischemia reperfusionneuro-inflammationovine fetusmonoclonal antibodies
spellingShingle Clémence Disdier
Xiaodi Chen
Jeong-Eun Kim
Steven W. Threlkeld
Barbara S. Stonestreet
Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period
Brain Sciences
brain
cytokines
ischemia reperfusion
neuro-inflammation
ovine fetus
monoclonal antibodies
title Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period
title_full Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period
title_fullStr Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period
title_full_unstemmed Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period
title_short Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period
title_sort anti cytokine therapy to attenuate ischemic reperfusion associated brain injury in the perinatal period
topic brain
cytokines
ischemia reperfusion
neuro-inflammation
ovine fetus
monoclonal antibodies
url http://www.mdpi.com/2076-3425/8/6/101
work_keys_str_mv AT clemencedisdier anticytokinetherapytoattenuateischemicreperfusionassociatedbraininjuryintheperinatalperiod
AT xiaodichen anticytokinetherapytoattenuateischemicreperfusionassociatedbraininjuryintheperinatalperiod
AT jeongeunkim anticytokinetherapytoattenuateischemicreperfusionassociatedbraininjuryintheperinatalperiod
AT stevenwthrelkeld anticytokinetherapytoattenuateischemicreperfusionassociatedbraininjuryintheperinatalperiod
AT barbarasstonestreet anticytokinetherapytoattenuateischemicreperfusionassociatedbraininjuryintheperinatalperiod